Aim: to study the dynamics of incidence, mortality, survival of patients with non-Hodgkin lymphomas in the world, Ukraine and Zaporizhzhya region in the 20th and at the beginning of the 21st century. The modern understanding of the etiology and prognostic factors of the disease was considered. Methods and results. In order to study the dynamics of incidence, mortality, survival of patients with non-Hodgkin lymphomas in the world, Ukraine, Zaporizhzhya region in the 20th and early 21st century the review of the specialized literature was conducted. We also considered the current ideas about etiology and risk factors of the disease. Non-Hodgkin lymphomas are complicated and poorly treatable diseases, which are found everywhere, and affect al...
Non-Hodgkin's lymphoma is a common condition whose incidence has increased by 75 % over the last 15 ...
Lymphomas which are neoplastic diseases that originate in lymphatic tissues such as lymph nodes, ton...
Trends in death certification rates from non-Hodgkin's lymphomas (NHL) were analyzed on the basis of...
Non-Hodgkin's lymphomas as lymphoproliferative disease are among the cancer is still increasing inci...
Objective: Non-Hodgkin’s Lymphoma (NHL) with a cancer burden of 3% is one of the most commonly repor...
Currently, Nohodzkin's lymphoma is one of the most common oncohematological diseases in the world. N...
Aims: To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin ly...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
The aim is to compare the cumulative incidence of Hodgkin's lymphoma and non-Hodgkin's lymphomas bet...
The aim. To analyse the peculiarities of the epidemiological situation on lymphogranulomatosis in th...
Non-Hodgkin lymphoma (NHL) prognosis has improved in recent years, yet the number of patients living...
Background: Non-Hodgkin lymphoma is a common hematologic malignancy. This article aimed to estimate ...
Introduction: Aggressive non-Hodgkin's lymphoma (NHL) is the most common malignant neoplasm of lymph...
Non-Hodgkin's lymphoma is a common condition whose incidence has increased by 75 % over the last 15 ...
Lymphomas which are neoplastic diseases that originate in lymphatic tissues such as lymph nodes, ton...
Trends in death certification rates from non-Hodgkin's lymphomas (NHL) were analyzed on the basis of...
Non-Hodgkin's lymphomas as lymphoproliferative disease are among the cancer is still increasing inci...
Objective: Non-Hodgkin’s Lymphoma (NHL) with a cancer burden of 3% is one of the most commonly repor...
Currently, Nohodzkin's lymphoma is one of the most common oncohematological diseases in the world. N...
Aims: To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin ly...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been risi...
The aim is to compare the cumulative incidence of Hodgkin's lymphoma and non-Hodgkin's lymphomas bet...
The aim. To analyse the peculiarities of the epidemiological situation on lymphogranulomatosis in th...
Non-Hodgkin lymphoma (NHL) prognosis has improved in recent years, yet the number of patients living...
Background: Non-Hodgkin lymphoma is a common hematologic malignancy. This article aimed to estimate ...
Introduction: Aggressive non-Hodgkin's lymphoma (NHL) is the most common malignant neoplasm of lymph...
Non-Hodgkin's lymphoma is a common condition whose incidence has increased by 75 % over the last 15 ...
Lymphomas which are neoplastic diseases that originate in lymphatic tissues such as lymph nodes, ton...
Trends in death certification rates from non-Hodgkin's lymphomas (NHL) were analyzed on the basis of...